Besides Bochen et al. found a high expression level of SEC62, defined as an IRS >0, to be significantly correlated with a shorter overall survival in IHC analyses of tissue specimens from 65 head and neck squamous cell carcinomas patients and 29 patients with cervical cancer of unknown primary (CUP) (Bochen et al., 2017). This evidence concerns the gene SEC62 and head and neck squamous cell carcinoma.